Buserelin

This classification denotes a gonadotropin-releasing hormone analog with the molecular formula C60H86N16O13, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier PXW8U3YXDV, chemically known as luteinizing hormone-releasing hormone (pig), 6-(o-(1,1-dimethylethyl)-d-serine)-9-(n-ethyl-l-prolinamide)-10-deglycinamide- but generally known as buserelin, which bears US NIH Compound Identifier 42615. Buserelin most often comes in base and acetate forms. European Medicines Agency schedules Buserelin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05991MIG. The term BUSERELIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 31, No10, 1977, List 17). World Health Organization schedules buserelin in its Anatomical Therapeutic Chemical (ATC) Classification. BUSERELIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule buserelin under HS 29371900 and SITC 54154. As of Q4 2014, BUSERELIN remains the US FDA Preferred Term for this commodity. Buserelin bears US NLM identifiers UMLS ID C0006456 and NCI Concept Code C320. SMILES: O=C(N1C(CCC1)C(=O)NCC)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C1NC(=O)CC1)CC1[NH]CNC1)CC1C2C([NH]C1)CCCC2)CO)CC1CCC(O)CC1)COC(C)(C)C)CC(C)C)CCC/N=C(/N)N.